@article{3bc576bbf4d54c149801df0163bbee76,
title = "Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal",
keywords = "PHASE-III TRIAL, WEEKLY PACLITAXEL, VINFLUNINE PLUS, SUPPORTIVE CARE, OPEN-LABEL, CARCINOMA, MONOTHERAPY, MULTICENTER, DOCETAXEL",
author = "Grimm, {Sabine E.} and Nigel Armstrong and Ramaekers, {Bram L. T.} and Xavier Pouwels and Shona Lang and Svenja Petersohn and Rob Riemsma and Gillian Worthy and Lisa Stirk and Janine Ross and Jos Kleijnen and Joore, {Manuela A.}",
year = "2019",
month = may,
doi = "10.1007/s40273-018-0723-5",
language = "English",
volume = "37",
pages = "655--667",
journal = "Pharmacoeconomics",
issn = "1170-7690",
publisher = "Adis International Ltd",
number = "5",
}